Edition:
United States

Profile: Neurosearch A/S (NEUR.CO)

NEUR.CO on Copenhagen Stock Exchange

4.40DKK
18 May 2018
Change (% chg)

kr.0.00 (+0.00%)
Prev Close
kr.4.40
Open
kr.4.47
Day's High
kr.4.48
Day's Low
kr.4.31
Volume
178,416
Avg. Vol
83,136
52-wk High
kr.5.20
52-wk Low
kr.2.80

Neurosearch A/S (NEUR) is Denmark-based biopharmaceutical company. It specializes in the research, development and sale of drug candidates. The Company’s portfolio comprises three products: Tesofensine, a drug used in obesity, which works as a monoamine reuptake inhibitor (MRI); Seridopidine, which is applied in central nervous system (CNS) diseases and acts as a dopaminergic stabilizer; and Ordopidine, a medicine, which also is involved in the CNS disease treatment as a dopaminergic stabilizer. Furthermore, the Company operates through three wholly owned subsidiaries, NeuroSearch Sweden AB, Poseidon Pharmaceutical A/S and NsExplorer A/S, as well as through affiliates, such as Atonomics A/S and NsGene A/S.

Company Address

Neurosearch A/S

Strandvejen 60
HELLERUP     2900
P: +4544.608000
F: +4544.608080

Company Web Links